Enochian Biosciences, Inc.
USD0.71
+0.01 (+1.79%)
CEO
Mark R. Dybul
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.73
Prev. Close
$0.70
Day Low
$0.70
Day High
$0.74
52W Low
$0.39
52W High
$2.99
Market Cap
$0.05B
Volume
0.09M
| 350,630 |
| $0.65 |
| 12 Sept 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 70,126 | $0.00 |
| 1 Aug 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 131,579 | $0.57 |
| 27 Jun 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 1,886,794 | $0.53 |
| 27 Jun 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 943,397 | $0.53 |
| 4 Apr 2023 | SAPIRSTEIN JAMES | director | A-Award | Acquired | 64,655 | $1.16 |
| 21 Mar 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 877,193 | $1.14 |
| 21 Mar 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 438,597 | $1.14 |
| 5 Jan 2023 | Alton Gregg H | director | A-Award | Acquired | 57,252 | $0.00 |